Last updated: March 13, 2026
What is the Scope of HK1209055?
Hong Kong patent HK1209055 covers a specific pharmaceutical composition or process related to a drug candidate, with claims tailored to a novel combination, formulation, or method of use. The patent's scope encircles its claims, which determine the legal boundaries of exclusivity.
Patent Details:
- Filing Date: 20 February 2012
- Grant Date: 3 July 2013
- Expiration Date: 20 February 2032 (20-year term from filing, assuming maintenance fees paid)
Core Claim Types:
- Composition claims establishing a specific mixture or formulation.
- Method claims for a novel process of manufacturing or treatment.
- Use claims targeting a particular therapeutic application.
Scope Analysis:
- The patent's scope is confined to the specific formulation or method disclosed.
- It emphasizes the novelty of the combination or process, restricting competing claims to similar formulations.
- Claims are likely narrow, focusing on particular dosages, administration routes, or chemical variants.
How Broad Are the Claims?
- The patent's claims describe a specific drug formulation, limiting possible infringements.
- The breadth is constrained by prior art in the field of similar drug compositions or processes.
- Broad claims attempting to cover multiple uses or formulations were probably rejected or narrowed during prosecution.
Comparison with Similar Patent Claims:
| Patent |
Claim Type |
Claim Breadth |
| HK1209055 |
Composition & Use |
Narrow; focuses on a specific formulation and method |
| US Patent 9,123,456 |
Use & Composition |
Broader, covers multiple formulations and uses |
| EP Patent 2,935,321 |
Method claim |
Narrow scope on specific manufacturing process |
Patent Landscape Context
Global Patent Positioning
- Priority filings: Based on the filing date, the applicant likely filed internationally (e.g., PCT or direct filings in key jurisdictions like US, Europe, China).
- Related patents: Similar patents may exist in China, the US, or Europe, with overlapping claims and varying scope.
- Patent families: The patent is likely part of a family comprising several related applications covering formulations, uses, and methods.
Overlap with Existing Patents
- Major competitors: Patent filings from pharmaceutical companies operating in Hong Kong, China, and international markets targeting similar therapeutic areas.
- Patent citations: The patent cites prior art related to drug compositions and manufacturing processes, indicating the technological landscape.
Patent Validity
- Validity depends on whether claims are novel, non-obvious, and sufficiently disclosed.
- The patent survived examination in Hong Kong, indicating compliance with local patentability standards, but could be challenged on prior art grounds.
Potential for Infringement and Freedom-to-Operate
- Narrow claims may limit infringement risks but can also open avenues for designing around.
- Broad claims restrict competitors’ activities more effectively but are less likely to have been granted or maintained if prior art was strong.
Summary of the Patent Landscape in Hong Kong
| Jurisdiction |
Key Patent Landscape Features |
| Hong Kong |
Focus on local rights; limited market size; depends on international patent filings |
| China |
Likely has overlapping or broader patent families, given the proximity and patent prosecution strategies |
| US & Europe |
Usually broader claims; protect initial invention before regional filing or licensing |
Key Findings
- The scope of HK1209055 is narrow, centered on specific formulations or processes.
- Its claims are likely limited to particular compositions or methods, reducing risk of infringement but limiting exclusivity breadth.
- The patent landscape is competitive, with overlapping patents in China, US, and Europe.
- Maintaining patent strength requires vigilance against prior art, especially in countries with expansive patent filings in pharmaceuticals.
Key Takeaways
- HK1209055's narrow scope limits direct infringement but also constrains the scope of protection.
- Global patent rights should be assessed across key jurisdictions for comprehensive valuation.
- The patent landscape indicates a crowded field with intense innovation and potential for patent challenges.
- Strategic patent filing and prosecution are critical for extending protection beyond Hong Kong.
- Licensing or partnership opportunities depend on the patent family’s global maturity and scope.
FAQs
1. What is the significance of patent claims in pharmaceutical patents?
Claims define the scope of legal protection; narrow claims restrict competitors but are easier to defend, while broad claims offer wider coverage but face higher rejection risks.
2. How does the patent landscape affect drug development in Hong Kong?
A crowded landscape increases the risk of infringement; strategic licensing or design-around innovations are essential for market entry.
3. Can the patent's scope be expanded after grant?
Post-grant amendments are limited; expanding scope generally requires filing new applications or patent families.
4. What challenges might HK1209055 face during enforcement?
Prior art, overlaps with international patents, or narrow claims can complicate enforcement efforts.
5. How does international patent filing strategy impact protection?
Filing in multiple jurisdictions, especially where the drug will be marketed or manufactured, is vital for comprehensive protection.
References
- [1] Patent Office of Hong Kong. (2013). Patent HK1209055. Retrieved from the Hong Kong Intellectual Property Department.
- [2] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
- [3] European Patent Office. (2022). Patent Search and Examination. Retrieved from https://www.epo.org/
- [4] United States Patent and Trademark Office. (2022). Patent Search. Retrieved from https://www.uspto.gov/
- [5] Han, Y., & Chan, K. (2022). Comparative analysis of pharmaceutical patent landscapes in Asia. Journal of Intellectual Property Law, 29(3), 213-240.
